acyclovir

Generic: acyclovir

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler camber pharmaceuticals, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

acyclovir 200 mg/5mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-681
Product ID 31722-681_e87a8107-f6d9-5bf2-e053-2a95a90afc80
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215669
Listing Expiration 2026-12-31
Marketing Start 2022-07-01

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722681
Hyphenated Format 31722-681

Supplemental Identifiers

RxCUI
307730
UPC
0331722681476
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA215669 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (31722-681-47)
source: ndc

Packages (1)

Ingredients (1)

acyclovir (200 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e87a8107-f6d9-5bf2-e053-2a95a90afc80", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0331722681476"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["2ca1395f-96b4-4543-8eed-bd07c62bbc7c"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (31722-681-47)", "package_ndc": "31722-681-47", "marketing_start_date": "20220701"}], "brand_name": "Acyclovir", "product_id": "31722-681_e87a8107-f6d9-5bf2-e053-2a95a90afc80", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "31722-681", "generic_name": "Acyclovir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA215669", "marketing_category": "ANDA", "marketing_start_date": "20220701", "listing_expiration_date": "20261231"}